there may be important differences between them. We carried out a systematic comparison of human iPS cells generated from hepatocytes (representative of endoderm), skin fibroblasts (mesoderm) and melanocytes (ectoderm). All low-passage iPS cells analysed retain a transcriptional memory of the original cells. The persistent expression of somatic genes can be partially explained by incomplete promoter DNA methylation. This epigenetic mechanism underlies a robust form of memory that can be found in iPS cells generated by multiple laboratories using different methods, including RNA transfection. Incompletely silenced genes tend to be isolated from other genes that are repressed during reprogramming, indicating that recruitment of the silencing machinery may be inefficient at isolated genes. Knockdown of the incompletely reprogrammed gene C9orf64 (chromosome 9 open reading frame 64) reduces the efficiency of human iPS cell generation, indicating that somatic memory genes may be functionally relevant during reprogramming.
epigenetic information. Transcriptional differences between human iPS cells and ES cells could not be explained by differences in histone modification patterns 4, 7 . Recent studies have identified differences in DNA methylation between iPS and ES cells in both mouse and human cells [9] [10] [11] [12] [13] [14] . Mouse iPS cells have been shown to retain a DNA methylation memory of the original somatic cell that may bias iPS cell differentiation towards lineages related to that cell 12, 14 . However, the DNA methylation differences found between iPS cells and ES cells were largely not demonstrated to correlate with gene expression differences [9] [10] [11] [12] [13] [14] . A further limitation stems from the fact that iPS cells generated in different laboratories by different methodologies are often used for comparison 4, 5 . In addition, most human iPS cells analysed so far, including in two very recent studies of genome-wide DNA methylation 9, 13 , are derived Phase  SSEA-3  SSEA-4  Tra1-60  Tra1-81 Hep-iPS3
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from fibroblasts, thus limiting the evaluation of a potential memory of the original somatic cell in iPS cells. We report here a systematic comparison of human iPS cells generated from different somatic cell types. Importantly, all iPS cells analysed by transcriptional profiling were generated with the same methodology and analysed in parallel. Our data allow us to distinguish different types of somatic cell memory in human iPS cells, which can be partially explained by incomplete promoter DNA methylation. We find that the somatic memory gene C9orf64 regulates the efficiency of iPS cell generation, and that incompletely silenced genes tend to be isolated from other genes destined to be silenced during reprogramming.
RESULTS

Generation of human iPS cells from somatic cells representative of all three embryonic germ layers
We used a doxycycline-inducible lentivirus transgene system 15, 16 to generate iPS cells ( Supplementary Fig. S1 ). To have a broad range of starting differentiated states, somatic cells representative of the three embryonic germ layers were reprogrammed to iPS cells: adult hepatocytes (Hep) for endoderm, newborn foreskin fibroblasts (Fib) for mesoderm and adult melanocytes (Mel) for ectoderm ( Supplementary  Fig. S1 ). The Mel-iPS cell lines have been previously described 17 . iPS cell pluripotency was extensively validated, including colony morphology, growth rate, marker expression, transgene independence, formation of embryoid bodies and development of teratomas 17 ( Fig. 1 and Supplementary Fig. S2 ). Integration analysis indicates that all iPS cell lines used are independent clones (data not shown). We focused our analysis in this study on low-passage iPS cells (below passage 20) , because they are expected to be more informative about the molecular mechanisms that underlie reprogramming.
Transcriptional profiling of iPS cells and ES cells
The expression levels in Hep, Fib, Mel and the iPS cells derived from them were profiled in triplicate. In addition, three independent well-established ES cell lines, H1, H7 and H9, and their 8-day (d8) embryoid bodies were also profiled individually. All samples were analysed using Affymetrix ST 1.0 microarrays (Supplementary Fig. S1 ). A hierarchical clustering of the data correctly classified the cell types as shown in Fig. 2a . The three iPS cell types clustered together with the ES cells, forming a single branch of pluripotent cell samples. Figure 2b further shows that all somatic cells underwent extensive reprogramming towards an ES cell-like transcriptional profile.
iPS cells retain a transcriptional memory of the original somatic cell
We used the equal-variance t statistic to find a global pattern of differential gene expression between iPS and ES cells. We plotted the gene expression differences between iPS cells and ES cells against the differences between the original somatic cells and ES cells and fitted locally weighted scatter plot smoothing (LOESS) regression curves to each plot ( Fig. 3a and Supplementary Data S1; see Methods). We then carried out bootstrap simulations to model noise in gene expression under the assumption that iPS and ES cells are truly identical and that their differences arise from random fluctuations. The actual regression curves lie well outside the intervals of simulated curves, revealing that genes that were highly expressed in somatic cells tend to be repressed but remain higher in iPS cells when compared with ES cells, and conversely for genes expressed at low levels in somatic cells (Fig. 3b) . This pattern was observed for all three types of iPS cell analysed (Fig. 3a,b and Supplementary Fig. S3a for Fib and Mel).
To find a confident set of differentially expressed genes, we used a robust statistical method, differential expression via distance synthesis (DEDS), which combines t -test, moderated t -test, fold change and significance analysis of microarrays into a summary statistic 18 . DEDS has been shown to outperform the individual statistics on spike-in data sets, and its synthesis approach also makes it robust against the limitations of individual tests 18 . At 5% false discovery rate (FDR), this analysis confirmed that a very significant proportion (∼50-60%) of the genes differentially expressed between iPS cells and ES cells represent a memory of the differential expression that already existed between the original somatic cells and ES cells (Fig. 3c , upper Venn diagrams). That is, a statistically significant (10 −6 > P > 10 −16 , Fisher's exact test) number of genes that were higher in iPS cells relative to ES cells resulted from incomplete silencing during reprogramming. Similarly, a statistically significant (10 −9 > P > 10 −32 , Fisher's exact test) number of genes that were lower in iPS cells relative to ES cells were the result of incomplete reactivation during reprogramming. No statistically significant overlap was found between genes that change in opposite directions in iPS cells and somatic cells, relative to ES cells (Fig. 3c , lower Venn diagrams). Our analysis thus demonstrates that iPS cells retain a transcriptional memory of the original somatic cells.
We next examined whether transcriptional memory in iPS cells is cell-type-specific or associated with multiple differentiated states. In support of a cell-type-specific transcriptional memory, ∼8 ± 2% of the genes differentially expressed between an iPS cell type and ES cells were already differentially expressed specifically in the original somatic cell (but not the other somatic cells), relative to ES cells ( Supplementary  Fig. S3b ). However, most of the genes differentially expressed between each iPS cell type and ES cells (52 ± 5% of total) were found to also be differentially expressed in two or all three somatic cell types relative Fig. S3b ). In addition, we do not find evidence of persistent expression of master transcriptional regulators of specific cell types. Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte differentiation 19 and regulates a class of melanocyte-specific genes. Our data show that MITF and its target genes TYR (tyrosinase) and TRPM1 (transient receptor potential cation channel, subfamily M, member 1) were successfully suppressed in Mel-iPS cells to levels similar to ES cells (DEDS q value = 0.3 for MITF). Similarly, the hepatocyte nuclear factor (HNF) transcription factors and their target genes highly expressed in hepatocytes 20 were reprogrammed in Hep-iPS to the ES cell state (the minimum DEDS q value for HNFs was 0.2). These findings indicate that key lineage-specifying transcription factors do not seem to play a major role in establishing a persistent somatic transcriptional memory in iPS cells.
Finally, we found no evidence that Hep-iPS cells are more efficient than Fib-iPS cells in targeted differentiation towards endoderm at both the messenger RNA and protein level (Supplementary Figs S4 and S5). We cannot exclude that differentiation biases towards the somatic cell type of origin may be observed using other targeted differentiation assays, as has been described in mouse iPS cells 12, 14 . Taken together, our data indicate that low-passage human iPS cells retain a transcriptional memory of the somatic cells, with common as well as cell-specific components.
DNA methylation can partially explain somatic gene expression in iPS cells
We next analysed available data on genome-wide DNA methylation in ES cells and fibroblasts 21 . The top incompletely silenced genes in iPS cells, such as C9orf64, TRIM4 (tripartite motif-containing 4) and COMT (catechol O-methyltransferase), showed preponderant promoter DNA methylation only in H1 ES cells and not in IMR90 lung fibroblasts (Supplementary Fig. S6 ). To carry out an unbiased assessment of the contribution of differential DNA methylation to the observed differential expression between iPS and ES cells ( Supplementary Fig. S7a ), the CpG (cytosine-phosphate-guanine) islands of all genes higher in each iPS cell type relative to ES cells were examined for cytosines differentially methylated between IMR90 and H1 (ref. 21) . Genes incompletely repressed in Fib-iPS cells showed a strong trend to be DNA methylated at their promoters in H1 ES cells, but not IMR90 fibroblasts ( C9orf64 = 0.78,P value = 0.02) for six genes with expression levels that remain higher in all three iPS cell types when compared with ES cells. mC ES>IMR90 is the number of cytosines in CpG islands with higher levels of methylation in H1 than IMR90. (c) The overall level of DNA methylation of four of the top somatic genes whose expression persists in low-passage iPS cells. The level of DNA methylation was examined with bisulphite sequencing analysis in three types of somatic cell (hepatocytes, fibroblasts and melanocytes), two clones for each iPS cell type and H1 and H9 human ES (hES) cells. The detailed bisulphite sequencing data for all samples can be found in Supplementary Data S2. (d) Higher-passage iPS cells retain incomplete DNA methylation at somatic cell memory genes. CpG island methylation levels were examined for our validated somatic memory genes (c) in five ES cell lines and six iPS cell lines with passage number >30 (passage range 30-58, data from a recent study 9 ). The box plot shows the difference in methylation levels between the higher-passage ES and iPS cells. One-sided Wilcoxon test P values confirm that C9orf64, TRIM4 and COMT are still resistant to promoter DNA methylation (that is, they are hypomethylated) in high-passage iPS cells relative to high-passage ES cells. No significant difference in the level of DNA methylation was found for the more variable of the four genes, CSRP1. DEDS q value < 0.05, Methods and Supplementary Fig. S7b ). Figure 4b shows that the correlation remains high if we consider only those genes that were differentially expressed in all three iPS cells when compared with ES cells, indicating that the contribution of DNA methylation to expression variation is not dependent on cell type. A similar analysis using CpG shores, 2-kilobase (kb)-long flanking regions of CpG islands that have previously been associated with incomplete reprogramming 22 , yielded only a weak explanation of R 2 = 0.02 for the observed variance in differential expression. Our data thus indicate that incomplete establishment of new promoter CpG DNA methylation may occur during reprogramming.
We next carried out bisulphite sequencing analysis of promoter CpG methylation for four of the top somatic genes whose expression persists in iPS cells, C9orf64, TRIM4, COMT and CSRP1 (cysteine and glycine-rich protein 1; Fig. 4c ). Consistent with the high expression levels of C9orf64, TRIM4 and COMT in somatic and iPS cells (Supplementary Table S1 ), the promoters of these three genes were depleted of CpG methylation in these cell types, but heavily methylated in ES cells ( Fig. 4c and Supplementary Data S2). Consistent with the pattern of gene expression, CSRP1 exhibited greater variability, but also showed the trend of being most methylated in ES cells, intermediately methylated in all iPS cells and least methylated in the somatic cells. We validated differential methylation using four other independent human ES cell lines and four other independent iPS cell lines, including iPS cells generated with different methods such as RNA transfection ( Supplementary Fig. S7c ). In addition, C9orf64, TRIM4 and COMT were also insufficiently methylated in six late-passage iPS cell lines when compared with five late-passage ES cell lines (all above passage 30), C9orf64  TSPYL5  DNAJC15  TRIM4  IQCA1  COMT  CAT  DNAJA4  HOXA7 Meta-analysis of DNA-methylation-associated transcriptional memory in independent data sets. (a) Thirty-seven genes expressed at higher levels in our Fib-iPS cells relative to ES cells tend to show higher expression in the iPS cells generated by Guenther et al. 7 and Warren et al. 29 , but there is high variability when expression data alone are used (cyan box plots). However, when we use 10 differentially expressed genes from our data that were also differentially DNA methylated in ES cells, a greater proportion show persistent higher expression in the iPS cells of the two data sets (yellow box plots). (b) The heat map shows the iPS/ES fold-change ranking of the 10 genes that are higher in our Fib-iPS cells and also methylated in ES cells. (The higher the rank, the greater the fold change.)
Shown are the Spearman rank correlation coefficients of fold changes between our data and those of Guenther et al. 7 and Warren et al. 29 . (c) Twenty-nine genes were expressed at significantly higher levels in iPS cells relative to ES cells in a pooled analysis of the Guenther et al. 7 and Warren et al. 29 data sets and were also differentially methylated in ES cells 21 . Differential expression was determined by applying meta-DEDS analysis to the pooled data set at a stringent cutoff of 0% FDR. The figure shows that the fold-change levels of those genes correlate significantly with DNA methylation levels (P value = 9.9 × 10 −4 ): the higher the fold change in iPS cells relative to ES cells, the higher the level of promoter DNA methylation in H1 ES cells relative to IMR90 fibroblasts.
which were analysed in a recent study 9 ( Fig. 4d) . These data indicate that the hypomethylated state of somatic cell genes can persist and correlate with expression in human iPS cells.
Meta-analysis confirms recurrent transcriptional memory associated with DNA methylation
We next sought to determine whether the genes associated with somatic cell memory in our data showed similar expression trends in other published data sets. A pooled analysis of eight different studies 4, 11, [23] [24] [25] [26] [27] [28] comparing human iPS cells and ES cells revealed that the most incompletely silenced genes in our data, C9orf64 and TRIM4, are within the top differentially expressed genes in these other studies, with an expression ∼4-fold higher in iPS than in ES cells (see Methods). We also compared our data with two recent studies that report large data sets comparing iPS cells with ES cells 7, 29 . Guenther et al. 7 profiled 7 different ES cell lines and 14 fibroblast-derived iPS cell lines, 6 of which had been treated to excise the reprogramming factors from the genome. Warren et al. 29 used synthetic mRNAs to reprogram four different types of fibroblast and also profiled H1 and H9 ES cell lines. We first pooled together the two data sets using meta-DEDS (mDEDS; ref. 30) , again synthesizing the aforementioned four statistical tests. At 5% FDR, 37 genes are higher in our Fib-iPS cells relative to ES cells, and 10 of them had higher DNA methylation levels in ES cells. Of these 37 genes, 68% are also higher in the pooled Guenther/Warren iPS cells when compared with ES cells (Fig. 5a , 'combined', Fisher test P = 7.4×10 −12 for the overlap). Strikingly, 9 out of the 10 differentially methylated genes were significantly higher in those iPS cells (Fig. 5a , Fisher test P = 8.3 × 10 −7 for the overlap). Not only was the overlap between the genes significant, but their expression levels relative to ES cells also correlated well with our data (Fig. 5b) . To test the robustness of this meta-analysis, we also analysed the Guenther and Warren data sets separately: 5 out of our 10 genes (Fisher test P = 5.8 × 10 −10 for the overlap) were also expressed at higher levels in the Guenther iPS cells. Seven out of our ten genes (Fisher test P = 1.0 × 10 −5 for the overlap)
were also expressed at higher levels in the Warren iPS cells. Finally, even at the more stringent cutoff of 0% FDR estimated by mDEDS, 6 out of 10 genes (C9orf64; testis-specific Y-encoded-like protein 5, TSPYL5; TRIM4; IQ motif containing with AAA domain 1, IQCA1; DnaJ (heat-shock protein 40) homologue, subfamily C, member 15, DNAJC15; catalase, CAT, Fisher test P = 2.1×10 −12 for the overlap) are still found to be expressed at higher levels in the pooled iPS cells.
We directly assessed a correlation between transcription and DNA methylation in the pooled data sets (Fig. 5c) . We carried out the expression/DNA methylation regression analysis described earlier (Fig. 4a,b) with the pooled Guenther and Warren data at 0% mDEDS FDR. Figure 5c shows that the log (iPS/ES) fold changes correlate significantly with promoter DNA methylation levels in H1 ES cells (Pearson correlation = 0.58, t distribution P value = 9.9 × 10 −4 ), similar to what we had observed for our data (Fig. 4a,b) . These results provide an independent validation of our findings that differences in levels of DNA methylation at certain somatic cell genes may underlie their expression in low-passage iPS cells, independent of laboratory-specific variability and reprogramming methods.
The incompletely reprogrammed gene C9orf64 regulates the efficiency of iPS cell generation
We tested whether the expression of incompletely reprogrammed genes in iPS cells is spurious or has any relevance for reprogramming. We carried out RNA-mediated interference (RNAi) for the top incompletely reprogrammed gene, C9orf64, in the context of iPS cell generation. We found that RNAi against C9orf64 during generation of human iPS cells, using three independent shRNAs, significantly decreased the total number of colonies staining positive for Tra1-81, compared with infection with the four factors alone or together with a non-targeting shRNA control (Fig. 6a) . The C9orf64-knockdown phenotype could be rescued by overexpression of an RNAi-immune complementary DNA (Supplementary Fig. S8 ). C9orf64 inhibition did not substantially reduce total cell numbers during the first 10 days of reprogramming, before the appearance of colonies (Fig. 6c) . These results indicate that C9orf64 is required for efficient iPS cell generation, although its mode of action remains to be determined.
Proximity in the genome affects efficiency of gene silencing in iPS cells
We next sought to gain insight into the mechanisms that underlie persistent expression of somatic genes in iPS cells. DNA methyltransferases (DNMTs) were detected at equivalent levels in iPS cells and ES cells (Fig. 7a) , indicating that the differential methylation observed between iPS cells and ES cells cannot be attributed to insufficient DNMT levels. There is no correlation between the density of promoter CpGs and the extent to which somatic genes are silenced (data not shown). Interestingly, we found a non-random pattern in the genomic locations of incompletely silenced genes: they tend to be isolated from other genes that undergo silencing on reprogramming (Fig. 7b) . These findings indicate that the recruitment of the silencing machinery, including DNMTs, may be inefficient or delayed at certain somatic genes that are 'left behind' owing to their isolation.
DISCUSSION
Our data document how remarkably similar to human ES cells are iPS cells generated from different somatic cell types. Nevertheless, we find that iPS cells retain a residual transcriptional memory of the somatic cells, and provide data in support of inefficient promoter DNA methylation as the underlying mechanism. Many factors may contribute to variability in gene expression in human iPS cells, including genetic background, starting somatic cell, method used for reprogramming, culture conditions, passage number and batch effects in microarray studies. Some of these same factors may also affect ES cells and have complicated an analysis of the potential transcriptional differences between human iPS cells and ES cells [4] [5] [6] [7] [8] . The strength of our study resided in comparing human iPS cells generated from different somatic cell types using the same methodology and analysed in parallel. Our use of gene expression and DNA methylation, rather than gene expression alone, allowed us to find evidence for somatic cell memory in other studies.
It has been shown that promoter DNA demethylation, a pre-requisite for gene reactivation, can be inefficient during generation of iPS cells 12, 31 . We report here that DNA methylation and silencing of somatic genes may also contribute to reprogramming (Fig. 8) . A complex balance between DNA demethylation and methylation is therefore likely to be critical for reprogramming. Our data indicate that care should be taken when using small molecules that promote DNA demethylation in iPS cells, and that an evaluation of the DNA methylation status of somatic cell genes may be warranted in the validation of new human iPS cell lines.
It is important to point out that most of our findings pertain to low-passage (<P20) human iPS cells, and that many of the differences relative to ES cells are expected to be attenuated, although possibly not completely abolished (see Fig. 4d ), with extensive passaging 4, 14 . The expression profile of ES cells, on the other hand, has been suggested to be relatively stable with passaging 4 . It will nevertheless be important to determine whether variability between ES cell lines, or any gene expression changes that ES cells may develop with continued culture, are also mediated by differential DNA methylation. The C9orf64 RNAi data indicate that some somatic genes may continue to be expressed in low-passage iPS cells because they play an active role during reprogramming. C9orf64 is a conserved gene of unknown function with no known protein domains. It is possible that it is required to stabilize an intermediate stage with characteristics of both the somatic and the reprogrammed state, although further studies will be required to address this.
Our data indicate that gene density can affect the efficiency with which genes are silenced. The proximity of multiple genes being repressed may synergize in recruiting the silencing machinery, whereas silencing may be inefficient or delayed in more isolated regions, where stochastic events thought to underlie the reprogramming process 32, 33 may have a lower probability of occurring (Fig. 8 ). It will be of interest to determine how positional effects in the genome affect the efficiency of epigenetic and transcriptional reprogramming.
Interestingly, several of the somatic cell memory genes reported here have been associated with cancer. TSPYL5 is silenced and DNA methylated in a subset of cancers [34] [35] [36] . C9orf64 is deleted in some cases of acute myeloid leukaemia 37 , and its promoter region is methylated in some breast cancer cell lines 38 . CSRP1 has been proposed to be a tumour suppressor silenced by DNA methylation in hepatocellular carcinoma 39 . It is therefore possible that deletion or epigenetic silencing of genes associated with somatic cell memory may contribute to cancer progression. Indeed, our preliminary findings indicate that the incompletely silenced genes reported here show a significant trend for downregulation during progression of hepatocellular carcinoma (data not shown). Our results prompt an evaluation of the role of somatic cell memory genes in cancer models. 
METHODS
Methods
DOI: 10.1038/ncb2239 METHODS
Lentivirus production. The doxycycline-inducible lentiviral vectors and a lentiviral vector constitutively expressing a reverse tetracycline transactivator (rtTA) used in our study have been previously described 16 . For virus production, 293T cells at 60-70% confluency were transfected in 10 cm plates with 4 µg of the lentiviral vectors together with 1 µg each of the packaging plasmids VSV-G, MDL-RRE and RSVr using Fugene 6 (Roche). Viral supernatants were collected after 72 h, filtered and concentrated with 1 ml of cold PEG-it Virus Precipitation Solution (System Biosciences) for every four volumes of virus. The virus supernatant and PEG-it mixture was incubated overnight at 4 • C. The mixture was centrifuged at 1,500 × g for 30 min at 4 • C, resuspended in 100 µl cold phosphate-buffered saline (PBS) and stored at −80 • C. Lentiviral infections were carried out in 1 ml of medium using 10 µl rtTA, 5 µl each of octamer-binding transcription factor 4 (OCT4), sex-determining region Y-box 2 (SOX2), Krueppel-like factor 4 (KLF4) and NANOG, and 2 µl cMYC per well of a six-well plate. Polybrene (8 µg ml −1 ; Sigma) was used for each infection.
Cell culture and human iPS cell generation. Human primary newborn foreskin (BJ) fibroblasts were obtained from ATCC (reference #: CRL-2522) and cultured in DMEM with 10% FBS, 1× glutamine, 1× non-essential amino acids, 1× sodium pyruvate, 2×penicillin/streptomycin, and 0.06 mM β-mercaptoethanol (fibroblast medium). For lentiviral infections of fibroblasts, 50,000 cells were plated per well of a six-well plate and infected overnight. The day after infection, the virus was removed and replaced with fresh fibroblast medium. At 48 h after infection, the infected cells from a single well of a six-well plate were trypsinized and seeded onto irradiated mouse embryonic feeders in DMEM/F12 with 20% KSR (knockout serum replacement), 0.5× glutamine, 1×non-essential amino acids, 2×penicillin/streptomycin, 0.1 mM β-mercaptoethanol, 10 ng ml −1 basic fibroblast growth factor (bFGF; human ES cell medium) containing 2% FBS and 1 µg ml −1 doxycycline in 10 cm plate format. The melanocytes were obtained from Promocell (reference #: C-12402). The NANOG transgene was not used for deriving Mel-iPS cells (only the doxycycline-inducible 4 factors were used 17 ). Adult human primary hepatocytes were obtained from Lonza (reference #: CC-2703W6) and cultured in human hepatocyte growth medium (HCM, Lonza). Hepatocytes were received as non-proliferating monolayers of cells shipped in a six-well plate format. On arrival, the shipping medium was replaced with fresh HCM and the cells were allowed to recover in a 5% CO 2 ,37 • C incubator for approximately 2 h before infection. Virus infections were carried out in 1 ml HCM per well of a six-well plate on two subsequent days. The day after the last infection, cells were mechanically dissociated into single cells and seeded in HCM onto irradiated mouse embryonic feeders in a 10 cm plate format. The following day, cells were transferred to human ES cell medium containing 1 µg ml −1 doxycycline and fed with this medium daily until the appearance of human ES cell-like colonies (up to 40 days). In all cases of human somatic cell reprogramming, Tra1-81 staining of live cells was carried out as previously published 26 .
Immunohistochemical analysis. Human ES and iPS cells were fixed directly in culturing plates (for pluripotency marker analysis) or on glass coverslips (for the targeted differentiation analysis) with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100. Cells were then stained with primary antibodies against SSEA-3 (MAB4303, Millipore, 1:100), SSEA-4 (MAB4304, Millipore, 1:100), Tra1-60 (ab16288, Abcam, 1:100), Tra1-81 (MAB4381, Millipore, 1:100), FOXA2 (07633, Upstate, 1:200), SOX17 (AF1924, R&D Systems, 1:1,000) and HNF1b (AF3330, R&D Systems, 1:100). Respective secondary antibodies were conjugated to either Alexa Fluor 594 or Alexa Fluor 488 (Invitrogen) and used at 1:500. Cell counting was done with Cellprofiler 2.0.
Quantitative PCR. RNA was isolated from cells using the RNeasy Mini RNA Isolation kit (Qiagen). cDNA was produced with the High-Capacity cDNA Reverse Transcription kit (Applied BioSystems) using random primers. Quantitative realtime PCR (rtPCR) reactions were carried out in triplicate with the SYBR Green quantitative rtPCR Master Mix (Applied BioSystems) and run on an Applied BioSystems 7900HT Sequence Detection System. Primer sequences are listed in Supplementary Table S3 .
Stochastic differentiation to embryoid bodies. Human ES and iPS cells were
lifted from feeder cells using a 1:1 ratio of dispase/collagenase IV mix (1 mg ml −1 each). The dispase/collagenase IV mixture (1 ml) was used per well of a sixwell plate. Cells were then grown in suspension culture with Knockout DMEM containing 20% FBS, 0.5× glutamine, 1× non-essential amino acids, and 0.1 mM β-mercaptoethanol. Embryoid bodies were collected and analysed at d8 for markers of the three embryonic germ layers.
Directed differentiation to endoderm. iPS and ES cells were differentiated
towards endoderm using a published protocol 40 ( Supplementary Fig. S4a ). Two clones each of Hep-iPS cells and Fib-iPS cells and two lines of ES cells (H1 and H9) were used in this analysis. Cells were collected on d3 (definitive endoderm stage) and d6 (primitive gut tube stage) after differentiation and processed for either quantitative rtPCR or immunohistochemical analysis.
Teratoma induction. Human ES and iPS cells were grown to 70-80% confluency in a six-well plate format and one entire plate-worth of cells was used to inject one immunocompromised SCID/Beige mouse subcutaneously into two sites near the hind flanks. Each six-well-plate-worth of cells was pelleted and resuspended in 140 µl of DMEM/F12 and immediately before injection, 60 µl of Matrigel (BD Biosciences) was mixed with the cells for a total volume of 200 µl. The cell/Matrigel mix (100 µl) was injected into each site. Tumours developed after 6-12 weeks and were processed for histological analysis.
Expression data analysis. The Affymetrix ST 1.0 expression data were normalized together using the robust multichip average (RMA) and the latest RefSeq probe mapping to the reference human genome 41, 42 . To minimize redundancy, RefSeq probes corresponding to the same Gene Symbol were combined if they showed no within-array variation for all 24 samples. This filtering process yielded a final list of 26,532 RefSeq genes. The equal-variance t -test was used to assess the significance of differential expression between groups. The expression profiles of the three ES cell lines were pooled together into one group. Analysis of variance (ANOVA) was carried out to find 453 genes that are significantly different among the eight groups (Hep, Hep-iPS, Fib, Fib-iPS, Mel, Mel-iPS, ES, EB) at a P-value cutoff of 10 −14 . Figure 2a shows the average-linkage clustering of the samples using those genes.
Bootstrap simulation. Assuming the null hypothesis that the log expression levels for each gene are identically distributed in ES and iPS cells, we estimated a normal null distribution separately for each gene by using maximum likelihood on the pooled data set of three iPS and three ES replicates. Six independent samples were then drawn from the normal distribution for each gene and grouped into three ES versus three iPS; one complete parametric bootstrap simulation consisted of such re-sampling for all RefSeq genes on the microarray. A LOESS curve was fitted to t -test P values for each bootstrap simulation. The entire process was repeated 1,000 times, and Fig. 3a shows the enveloping curves for the simulated LOESS regression.
Independent confirmation of incompletely silenced genes.
We pooled together 24 iPS cell and 18 ES cell expression profiles from Gene Expression Omnibus (GSE18226, GSE14711, GSE9865, GSE16654, GSE6561, GSE7896, GSE9440, GSE15176). The data were normalized together using RMA and then corrected for potential batch effects using an empirical Bayes method 43 .
Meta-analysis of published iPS cell expression profiles. The data from
Guenther et al. 7 (GSE23402) and Warren et al. 29 (GSE23583) were normalized together using RMA, as described above. We used the Bioconductor package DEDS (ref. 18). We carried out 2,000 permutations and used 5% FDR as a cutoff for deciding differential expression. Meta-DEDS was used to pool together the two data sets, again applying 2,000 permutations and 5% or 0% FDR.
CpG methylation analysis.
We consider a CpG island to be associated with a gene if it contains the transcription start site of the gene or if one of its edges lies within 2 kb from the transcription start site of the gene. Using the DEDS method 18 , 64 RefSeq genes were found to be expressed at a higher level in Fib-iPS cells than ES cells at the q-value cutoff of 0.05. Among the 64 genes, 12 genes had differentially methylated cytosines between IMR90 and ES cells in their CpG islands located within 2 kb.
For the 12 genes, we define f = log expression fold change between Fib-iPS and ES. (Note that f > 0 if the expression is higher in the iPS cell.)
Let mC ES>IMR90 = number of C with higher methylation in ES when compared with IMR90.
Let mC IMR90>ES = number of C with higher methylation in IMR90 when compared with ES.
The Pearson correlation between f and mC ES>IMR90 in the corresponding CpG island is 0.80 and the P value for the correlation is 1.9 × 10 −3 . (The corresponding correlation and P value are 0.37 and 5.1×10 −3 for Hep-iPS and 0.74 and 2.5×10 −3 for Mel-iPS.) Six genes were differentially expressed in all iPS cells when compared with ES cells at a DEDS q-value cutoff of 0.05 and had differentially methylated CpG islands between IMR90 and ES cells. The Pearson correlation between f and mC ES>IMR90 for those genes is 0.88 and P value = 0.02.
A least-squares linear regression model was fitted to the log differential expression fold changes with mC ES>IMR90 and mC IMR90>ES as two predictors. Only mC ES>IMR90 , and not mC IMR90>ES , contributed significantly to the model. The statistical package R was used for the computations. Table S2 ) and were subsequently cloned using pCR2.1/TOPO (Invitrogen). Individual bacterial colonies were subjected to PCR using vector-specific primers and sequenced using an ABI 3700 automated DNA sequencer.
RNAi in reprogramming.
Newborn foreskin fibroblasts were seeded at 30,000 cells per well of a six-well plate the day before infection. Cells were infected with 0.5 µl each of concentrated retroviruses (obtained from the Harvard Gene Therapy Initiative), leading to the overexpression of OCT4, SOX2 and KLF4, and 0.05 µl in the case of cMYC, alone or in combination with 50 µl of non-concentrated lentivirus for a non-targeting shRNA (5 -ATCTCGCTTGGGCGAGAGTAAG-3 ), C9orf64 shRNA (three independent shRNAs-shRNA1: 5 -CATGTTTGCTGATTATAGA-3 ; shRNA2: 5 -CTTTGATATTTAGAGAACA-3 ; shRNA3: 5 -GAGGTTATAGGAAATTGAT-3 ) or a p53 shRNA (5 -GACTCCAGTGGTAATCTACT-3 ). Cells were infected in 1 ml human ES cell medium (see the section, Cell culture and human iPS cell generation) and 8 µg ml −1 polybrene. Cells remained in the presence of virus for 48 h and on the day after virus addition, 1 ml of fibroblast medium was added. At 48 h after infection, virus was removed and cells were cultured in ES cell medium. On d20-d28 after infection, Tra1-81 staining of live cells was carried out to identify fully reprogrammed iPS cell colonies.
Accession numbers. The microarray data are available from Gene Expression
Omnibus under access number GSE23034. 
